col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


79 Results       Page 1

 [1] 
Frontiers Media SA: Frontiers in Virology
  original article Date Title Authors   All Authors
1 [GO] 2026―Jun―03 Prevalence of pre-diabetes, newly diagnosed diabetes, and associated COVID-19 disease severity in patients hospitalized at Sir Ketumile Masire Teaching Hospital, Botswana Kabelo Bakgethisi, Sikhulile Moyo, Graceful Mulenga, Lynnette N. Bhebhe, Elizabeth Botsile, Peter Vuylsteke, Tendani Gaolatlhe
2 [GO] 2026―May―22 Correction: Re-opening the question of lower SARS-CoV-2 attack rates in active smokers: a perspective on viral interference and Tobacco Mosaic Virus Ernesto de Bernardis, Fabio Lugoboni, Lina Busà, Giulio Petronio Petronio, Roberto Di Marco
3 [GO] 2026―Apr―21 Editorial: SARS-CoV-2: virology, epidemiology, diagnosis, pathogenesis and control, volume II Severino Jefferson Ribeiro da Silva, Larissa Krokovsky, Ronaldo Celerino da Silva, Zhen Qin
4 [GO] 2026―Apr―02 Acid sphingomyelinase inhibition as an antiviral strategy: mechanisms, functional inhibitors, and therapeutic potential against SARS-CoV-2 and beyond Suvechha Bhandari, Abimbola O. Kolawole, Craig A. Rohan, Jeffrey B. Travers
5 [GO] 2026―Apr―01 Evolutionary dynamics of Erinaceus coronavirus in Italy: spike protein adaptation and variable CD200 ortholog insertion Luca De Sabato, Ilaria Di Bartolo, Irene Berselli, Giovanni Ianiro, Marina Monini, Monica Giammarioli, et al. (+24)
6 [GO] 2026―Mar―27 Re-opening the question of lower SARS-CoV-2 attack rates in active smokers: a perspective on viral interference and Tobacco Mosaic Virus Ernesto de Bernardis, Fabio Lugoboni, Lina Busà, Giulio Petronio Petronio, Roberto Di Marco
7 [GO] 2026―Mar―25 Microbiota-derived succinic acid boosts antiviral activity of AKT targeting in coronaviruses Hanhan Feng, Xiaofeng Liu, Nanping Wu
8 [GO] 2026―Mar―05 Distinguishing the clinical types and laboratory markers of the ancestral and Omicron variants of COVID-19: a multicenter retrospective study Xiongwen Tu, Huijuan Li, Zhenjun Liu, Yusheng Cheng, Lingling Li
9 [GO] 2026―Jan―12 From COVID-19 to global health: challenges and opportunities in mRNA vaccine manufacturing Varun Choudhary, Anirudh Mehta, Moazam Niaz, Aditya Pradeep Sohoni, Pooja Dave, Urenna Nwagwu, Abdul Samad
10 [GO] 2025―Nov―20 Effects of the cross-talk between PARP12/PARP13 and nonsense mediated RNA decay pathway on RNA stability and replication of SARS-CoV-2 Nandadeva Lokugamage, Subhadip Choudhuri, Kempaiah Rayavara, Chien-Te Tseng, Shinji Makino, Nisha Jain Garg
11 [GO] 2025―Nov―17 Oral administration of Korean perilla frutescens leaf extract shows potential therapeutic effects against COVID-19 in a SH101 hamster model Jin-Soo An, Woong-Il Kim, Seong-Tshool Hong, Hae-Mi Kim, Oh-Young Kwon, Jae-Hyun Lee, et al. (+4)
12 [GO] 2025―Jan―24 Impact of COVID-19 pandemic restrictions and relaxation on pediatric respiratory virus hospitalizations in Southwest China: a retrospective study Ting Gong, Fengqi He, Yongle Zhao, Shuya Lu, Daiyin Tian
13 [GO] 2024―Dec―19 Editorial: Impact of the SARS-CoV-2 pandemic on the evolution and epidemiology of other viruses Alfonso J. Rodríguez-Morales, Jorge X. Velasco-Hernández, Andreu Comas-Garcia
14 [GO] 2024―Nov―08 Seroprevalence of anti-SARS-CoV-2 IgM and IgG and COVID-19 vaccine uptake in healthy volunteers in Nairobi, Kenya: a cross-sectional study Agnes Muhonja Otindo, Eric M. Ndombi, Martin Theuri, Margaret Muturi, Peris Thamaini, James Ogutu, et al. (+6)
15 [GO] 2024―Oct―28 Human cellular restriction factors that target SARS-CoV-2 replication Amukelani Marivate, Shani Bekker, Muhammad Qasim Fish, Salerwe Mosebi
16 [GO] 2024―Oct―18 Klebsiella pneumoniae co-infection leads to fatal pneumonia in SARS-CoV-2-infected mice Crystal Villalva, Girish Patil, Sai Sankara Narayanan, Roshan Ghimire, Debarati Chanda, Nishantha Samarakoon, et al. (+4)
17 [GO] 2024―Oct―03 An overview of SARS-CoV-2 viral proteins with relevance to improved diagnostic and therapeutic platforms Christopher Chung, Pratiba Irudayaraj, Emran Lallow, Ziyang Xu, Young K. Park, Sagar B. Kudchodkar, et al. (+3)
18 [GO] 2024―Aug―06 Severe acute respiratory syndrome coronavirus-2 seroprevalence in non-vaccinated people living with HIV in Uganda during 2022 Provia Ainembabazi, Letisha Najjemba, Joseph Musaazi, Mario Hönemann, Barbara Castelnuovo, Amrei von Braun
19 [GO] 2024―Jul―19 Predicting antibody and ACE2 affinity for SARS-CoV-2 BA.2.86 and JN.1 with in silico protein modeling and docking Shirish Yasa, Sayal Guirales-Medrano, Denis Jacob Machado, Colby T. Ford, Daniel Janies
20 [GO] 2024―Jul―16 Investigation of COVID-19 virus mutagenicity and the effect of the NSP13, NSP14, and NSP16 on the -1 ribosomal frameshifting Ali Khanifar, Azin Najafi, Jaber Hemmati, Fatemeh Nouri, Seyed Ali Hosseini, Mohammad Taheri
21 [GO] 2024―May―29 No detectable differences in Nef-mediated downregulation of HLA-I and CD4 molecules among HIV-1 group M lineages circulating in Cameroon, where the pandemic originated Nelson Sonela, Jaclyn Mann, Celestin Godwe, Oumarou H. Goni, Mérime Tchakoute, Nathalie Nkoue, et al. (+5)
22 [GO] 2024―Apr―12 Editorial: SARS-CoV-2: virology, epidemiology, diagnosis, pathogenesis, and control Severino Jefferson Ribeiro da Silva, Sachin Kumar, Lindomar Pena
23 [GO] 2024―Mar―14 Virological characteristics correlating with SARS-CoV-2 spike protein fusogenicity MST Monira Begum, Kimiko Ichihara, Otowa Takahashi, Hesham Nasser, Michael Jonathan, Kenzo Tokunaga, et al. (+6)
24 [GO] 2024―Mar―06 DNA methylation in long COVID Yangfan Xiao, Sten H. Vermund
25 [GO] 2024―Jan―08 Trends in the enterovirus surveillance in Oslo, Norway before and during the COVID-19 pandemic Susanne Dudman, Ingvild Klundby, Joakim Øverbø, Sanela Numanovic, Mariann Nilsen, Andreas Lind, et al. (+2)
26 [GO] 2023―Dec―22 Characterization of the evolutionary and virological aspects of mutations in the receptor binding motif of the SARS-CoV-2 spike protein Yuuka Masuda, Hesham Nasser, Jiri Zahradnik, Shuya Mitoma, Ryo Shimizu, Kayoko Nagata, et al. (+7)
27 [GO] 2023―Oct―27 Brief research report: OM-85 reduces SARS-COV-2 viral RNA expression in nasopharyngeal cells from COVID-19 patients Gisele Cassão, Krist Helen Antunes, João Ismael Budelon Gonçalvez, Leonardo Duarte Santos, Bruno Lopes Abbadi, Cristiano Valim Bizarro, et al. (+5)
28 [GO] 2023―Aug―30 A cell-based, SARS-CoV-2 spike protein interaction assay to inform the neutralising capacity of recombinant and patient sera antibodies Neale Harrison, Lauren Richardson, Chiara Pallini, Ines Morano, Elizabeth Jinks, Jamie Cowley, et al. (+17)
29 [GO] 2023―Jun―06 Clinical and serological characteristics of symptomatic infection with seasonal human coronaviruses OC43, HKU1, NL63, and 229E in community-dwelling older adults Marije K. Verheul, Marion Hendriks, Caroline Vilas Boas de Melo, Sophie van Tol, Gert-Jan Godeke, Rob van Binnendijk, et al. (+3)
30 [GO] 2023―Apr―26 Predicting changes in neutralizing antibody activity for SARS-CoV-2 XBB.1.5 using in silico protein modeling Colby T. Ford, Shirish Yasa, Denis Jacob Machado, Richard Allen White, Daniel A. Janies
31 [GO] 2023―Mar―24 Co-detection of respiratory syncytial virus with other respiratory viruses across all age groups before and during the COVID-19 pandemic Haya Hayek, Justin Z. Amarin, Yasmeen Z. Qwaider, Asim Khanfar, Tess Stopczynski, Jonathan Schmitz, et al. (+5)
32 [GO] 2023―Mar―06 Oral intake of heat-killed Lactiplantibacillus pentosus ONRICb0240 partially protects mice against SARS-CoV-2 infection Maki Kiso, Ryuta Uraki, Mutsumi Ito, Seiya Yamayoshi, Yoshifumi Kotani, Masaki Imai, et al. (+2)
33 [GO] 2023―Mar―06 Frequent use of IGHV3-30-3 in SARS-CoV-2 neutralizing antibody responses Pradeepa Pushparaj, Andrea Nicoletto, Xaquin Castro Dopico, Daniel J. Sheward, Sungyong Kim, Simon Ekström, et al. (+3)
34 [GO] 2023―Mar―03 Willingness to accept COVID-19 vaccine and its determinants in Ethiopia: A systematic review and meta-analysis Tadesse Tolossa, Getahun Fetensa, Bikila Regassa Feyisa, Bizuneh Wakuma, Matiyos Lema
35 [GO] 2023―Mar―03 Epitope mapping of SARS-CoV-2 spike protein differentiates the antibody binding activity in vaccinated and infected individuals Nathaniel Felbinger, David Trudil, Lawrence Loomis, Richard Ascione, Gregory Siragusa, Seiji Haba, et al. (+7)
36 [GO] 2023―Mar―01 SARS-CoV-2 infects multiple species of North American deer mice and causes clinical disease in the California mouse Juliette Lewis, Shijun Zhan, Allison C. Vilander, Anna C. Fagre, Tawfik A. Aboellail, Hippokratis Kiaris, Tony Schountz
37 [GO] 2023―Feb―23 Detecting punctuated evolution in SARS-CoV-2 over the first year of the pandemic Kevin Surya, Jacob D. Gardner, Chris L. Organ
38 [GO] 2023―Feb―08 Previous exposure to common coronavirus HCoV-NL63 is associated with reduced COVID-19 severity in patients from Cape Town, South Africa Lida C. Lesmes-Rodríguez, Humaira Lambarey, Abeen Chetram, Catherine Riou, Robert J. Wilkinson, Wendy Joyimbana, et al. (+4)
39 [GO] 2023―Jan―04 In-depth genetic characterization of the SARS-CoV-2 pandemic in a two-year frame in North Macedonia using second and third generation sequencing technologies Maja Vukovikj, Golubinka Boshevska, Elizabeta Janchevska, Teodora Buzharova, Ardian Preshova, Milica Simova, et al. (+5)
40 [GO] 2022―Dec―23 Renewed global threat by the novel SARS-CoV-2 variants ‘XBB, BF.7, BQ.1, BA.2.75, BA.4.6’: A discussion Ranjan K. Mohapatra, Ahmed Mahal, LV Simhachalam Kutikuppala, Madhumita Pal, Venkataramana Kandi, Ashish K. Sarangi, et al. (+2)
41 [GO] 2022―Dec―14 Cytoplasmic ribonucleoprotein complexes, RNA helicases and coronavirus infection Li Wang, María Guzmán, Isabel Sola, Luis Enjuanes, Sonia Zuñiga
42 [GO] 2022―Dec―01 SARSNTdb database: Factors affecting SARS-CoV-2 sequence conservation John Orgera, James J. Kelley, Omri Bar, Sathyanarayanan Vaidhyanathan, Andrey Grigoriev
43 [GO] 2022―Oct―19 Corrigendum: MSH3 Homology and Potential Recombination Link to SARS-CoV-2 Furin Cleavage Site Balamurali K. Ambati, Akhil Varshney, Kenneth Lundstrom, Giorgio Palú, Bruce D. Uhal, Vladimir N. Uversky, Adam M. Brufsky
44 [GO] 2022―Oct―11 Commentary: MSH3 homology and potential recombination link to SARS-CoV-2 furin cleavage site Yseulys Dubuy, Hugo Lachuer
45 [GO] 2022―Oct―07 Corrigendum: Investigating the evolutionary origins of the first three SARS-CoV-2 variants of concern Mahan Ghafari, Qihan Liu, Arushi Dhillon, Aris Katzourakis, Daniel B. Weissman
46 [GO] 2022―Sep―23 Starting signal: Aberrant kinase activation as a trigger for SARS-CoV-2 induced axonal damage Alexsia Richards, Rudolf Jaenisch
47 [GO] 2022―Sep―23 SARS-CoV-2 vertical transmission supports innate fetal protection: A narrative review Eytan R. Barnea, Nicoletta Di Simone, Soren Hayrabedyan, Krassimira Todorova, Annalisa Inversetti, Giovanni Vento, Simonetta Costa
48 [GO] 2022―Sep―14 SARS-CoV-2 variants from COVID-19 positive cases in the Free State province, South Africa from July 2020 to December 2021 Peter Mwangi, Javan Okendo, Milton Mogotsi, Ayodeji Ogunbayo, Olusesan Adelabu, Hlengiwe Sondlane, et al. (+16)
49 [GO] 2022―Sep―09 Mutations in SARS-CoV-2 nucleocapsid in variants of concern impair the sensitivity of SARS-CoV-2 detection by rapid antigen tests Ibrahim T. Hagag, Krzysztof Pyrc, Saskia Weber, Anne Balkema-Buschmann, Martin H. Groschup, Markus Keller
50 [GO] 2022―Sep―02 Investigating the evolutionary origins of the first three SARS-CoV-2 variants of concern Mahan Ghafari, Qihan Liu, Arushi Dhillon, Aris Katzourakis, Daniel B. Weissman
51 [GO] 2022―Jul―13 Epigallocatechin Gallate and Isoquercetin Synergize With Remdesivir to Reduce SARS-CoV-2 Replication In Vitro Henintsoa Rabezanahary, Ashraf Badr, Liva Checkmahomed, Kim Pageau, Yves Desjardins, Mariana Baz
52 [GO] 2022―Jul―07 SARS-CoV-2 and the Missing Link of Intermediate Hosts in Viral Emergence - What We Can Learn From Other Betacoronaviruses Brayden G. Schindell, Meagan Allardice, Jessica A.M. McBride, Brendan Dennehy, Jason Kindrachuk
53 [GO] 2022―Jul―07 Rapid and Affordable High Throughput Screening of SARS-CoV-2 Variants Using Denaturing High-Performance Liquid Chromatography Analysis Maria Elena Turba, Domenico Mion, Stavros Papadimitriou, Francesca Taddei, Giorgio Dirani, Vittorio Sambri, Fabio Gentilini
54 [GO] 2022―Jul―04 Disrupting ACE2 Dimerization Mitigates the Infection by SARS-CoV-2 Pseudovirus Jiaqi Zhu, Yue Su, Young Tang
55 [GO] 2022―Jul―01 Changes in Symptoms Experienced by SARS-CoV-2-Infected Individuals - From the First Wave to the Omicron Variant Hansjörg Schulze, Wibke Bayer
56 [GO] 2022―Jun―30 Dimethoxycurcumin Acidifies Endolysosomes and Inhibits SARS-CoV-2 Entry Nabab Khan, Zahra Afghah, Aparajita Baral, Jonathan D. Geiger, Xuesong Chen
57 [GO] 2022―Jun―24 SARS-CoV-2 Genomic Surveillance Enables the Identification of Delta/Omicron Co-Infections in Argentina María Belén Pisano, Paola Sicilia, Maximiliano Zeballos, Andrea Lucca, Franco Fernandez, Gonzalo M. Castro, et al. (+5)
58 [GO] 2022―May―24 Immune Responses of a Novel Bi-Cistronic SARS-CoV-2 DNA Vaccine Following Intradermal Immunization With Suction Delivery Moonsup Jeong, Sagar B. Kudchodkar, Areum Gil, Bohyun Jeon, Gee Ho Park, Youngran Cho, et al. (+31)
59 [GO] 2022―May―06 Alpha, Beta, Delta, Omicron, and SARS-CoV-2 Breakthrough Cases: Defining Immunological Mechanisms for Vaccine Waning and Vaccine-Variant Mismatch Benjamin Hewins, Motiur Rahman, Jesus F. Bermejo-Martin, Alyson A. Kelvin, Christopher D. Richardson, Salvatore Rubino, et al. (+5)
60 [GO] 2022―Apr―29 Therapeutic Potential of Long Non-Coding RNAs of HIV-1, SARS-CoV-2, and Endogenous Retroviruses Andrea Virginia Ruiz Ramírez, Ernesto Prado Montes de Oca
61 [GO] 2022―Apr―14 Identification of Compounds With Antiviral Activity Against SARS-CoV-2 in the MMV Pathogen Box Using a Phenotypic High-Throughput Screening Assay Laís D. Coimbra, Alexandre Borin, Marina Fontoura, Humberto D. Gravina, Alice Nagai, Jacqueline Farinha Shimizu, et al. (+11)
62 [GO] 2022―Apr―13 Investigating the Extent of Primer Dropout in SARS-CoV-2 Genome Sequences During the Early Circulation of Delta Variants Loïc Borcard, Sonja Gempeler, Miguel A. Terrazos Miani, Christian Baumann, Carole Grädel, Ronald Dijkman, et al. (+5)
63 [GO] 2022―Mar―29 Efficient Screening of Long Oligonucleotides Against Hundred Thousands of SARS-CoV-2 Genome Sequences Manfred Weidmann, Elena Graf, Daniel Lichterfeld, Ahmed Abd El Wahed, Michaël Bekaert
64 [GO] 2022―Mar―29 Serum Proteomics Identifies Immune Pathways and Candidate Biomarkers of Coronavirus Infection in Wild Vampire Bats Daniel J. Becker, Guang-Sheng Lei, Michael G. Janech, Alison M. Bland, M. Brock Fenton, Nancy B. Simmons, et al. (+2)
65 [GO] 2022―Mar―24 Transcriptome Analysis of Lungs in a Mouse Model of Severe COVID-19 Inbar Cohen-Gihon, Ofir Israeli, Avital Tidhar, Anita Sapoznikov, Yentl Evgy, Dana Stein, et al. (+7)
66 [GO] 2022―Feb―28 Genomic Characterization of the Emerging SARS-CoV-2 Lineage in Two Districts of Campania (Italy) Using Next-Generation Sequencing Marianna Scrima, Alessia Maria Cossu, Egildo Luca D'Andrea, Marco Bocchetti, Ylenia Abruzzese, Clara Iannarone, et al. (+11)
67 [GO] 2022―Feb―21 MSH3 Homology and Potential Recombination Link to SARS-CoV-2 Furin Cleavage Site Balamurali K. Ambati, Akhil Varshney, Kenneth Lundstrom, Giorgio Palú, Bruce D. Uhal, Vladimir N. Uversky, Adam M. Brufsky
68 [GO] 2022―Feb―08 Placental Macrophages Following Maternal SARS-CoV-2 Infection in Relation to Placental Pathology Megan C. Sharps, Ainslie Garrod, Emmanuel Aneni, Carolyn J. P. Jones, Gauri Batra, Alexander E. P. Heazell
69 [GO] 2022―Feb―07 Predictions of the SARS-CoV-2 Omicron Variant (B.1.1.529) Spike Protein Receptor-Binding Domain Structure and Neutralizing Antibody Interactions Colby T. Ford, Denis Jacob Machado, Daniel A. Janies
70 [GO] 2022―Feb―04 Persistent SARS-CoV-2 Infection in a Patient With Non-hodgkin Lymphoma: Intra-Host Genomic Diversity Analysis Angelica Bianco, Loredana Capozzi, Laura Del Sambro, Domenico Simone, Lorenzo Pace, Valeria Rondinone, et al. (+5)
71 [GO] 2022―Jan―12 SARS-CoV-2 and the Host Cell: A Tale of Interactions Massimo Pizzato, Chiara Baraldi, Giulia Boscato Sopetto, Davide Finozzi, Carmelo Gentile, Michele Domenico Gentile, et al. (+8)
72 [GO] 2021―Dec―15 Saliva for COVID-19 Testing: Simple but Useless or an Undervalued Resource? Sara Pijuan-Galito, Francesco Saverio Tarantini, Hannah Tomlin, Harry Jenkins, Jamie Louise Thompson, Danielle Scales, et al. (+27)
73 [GO] 2021―Dec―15 Iota-Carrageenan Prevents the Replication of SARS-CoV-2 in a Human Respiratory Epithelium Cell Line in vitro Augusto Varese, Ana Paletta, Ana Ceballos, Carlos Adolfo Palacios, Juan Manuel Figueroa, Andrea Vanesa Dugour
74 [GO] 2021―Dec―01 Improved SARS-CoV-2 Spike Glycoproteins for Pseudotyping Lentiviral Vectors Paul G. Ayoub, Arunima Purkayastha, Jason Quintos, Curtis Tam, Lindsay Lathrop, Kevin Tam, et al. (+4)
75 [GO] 2021―Nov―30 SNP and Phylogenetic Characterization of Low Viral Load SARS-CoV-2 Specimens by Target Enrichment Gregory S. Orf, Kenn Forberg, Todd V. Meyer, Illya Mowerman, Aurash Mohaimani, Matthew L. Faron, et al. (+6)
76 [GO] 2021―Nov―19 Reliability of Wastewater Analysis for Monitoring COVID-19 Incidence Revealed by a Long-Term Follow-Up Study Rafael Sanjuán, Pilar Domingo-Calap
77 [GO] 2021―Oct―01 GAPDH, Interferon γ, and Nitric Oxide: Inhibitors of Coronaviruses Aashir Awan
78 [GO] 2021―May―28 Case Report: Early Transcontinental Import of SARS-CoV-2 Variant of Concern 202012/01 (B.1.1.7) From Europe to Uruguay Cecilia Salazar, Alicia Costabile, Ignacio Ferrés, Paula Perbolianachis, Marianoel Pereira-Gómez, Diego Simón, et al. (+7)
79 [GO] 2021―Mar―25 Translational Virology in the Age of Pandemics Kenneth Lundstrom
 [1] 

79 Results       Page 1


[de][en]

Last change 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.004 sec